Table_1_The effects of pharmaceutical interventions on potentially inappropriate medications in older patients: a systematic review and meta-analysis.DOCX by Shuang Zhou (339964)

“…As various interventions have been developed to manage it, we performed a systematic review and meta-analysis to evaluate the effect of pharmaceutical interventions on outcomes of PIMs in older patients.…”

Pyrethroid resistance persists after ten years without usage against <i>Aedes aegypti</i> in governmental campaigns: Lessons from São Paulo State, Brazil by Maria de Lourdes Macoris (5043386)

“…</p><p>Methodology/Principal findings</p><p>We evaluated pyrethroid resistance in <i>Ae</i>. …”

Table_2_The effects of pharmaceutical interventions on potentially inappropriate medications in older patients: a systematic review and meta-analysis.DOCX by Shuang Zhou (339964)

“…As various interventions have been developed to manage it, we performed a systematic review and meta-analysis to evaluate the effect of pharmaceutical interventions on outcomes of PIMs in older patients.…”

Table 2_A machine learning model to predict neurological deterioration after mild traumatic brain injury in older adults.docx by Daisu Abe (20498225)

“…Neurological deterioration was defined as a decrease of 2 or more points from a GCS score of 13 or more within 24 h of hospital admission. …”

Table 3_A machine learning model to predict neurological deterioration after mild traumatic brain injury in older adults.docx by Daisu Abe (20498225)

“…Neurological deterioration was defined as a decrease of 2 or more points from a GCS score of 13 or more within 24 h of hospital admission. …”

Effects of linagliptin on cardiovascular and kidney outcomes in people with normal and reduced kidney function: secondary analysis of the CARMELINA randomized trial by Vlado Perkovic (141532)

Image_2_The effects of pharmaceutical interventions on potentially inappropriate medications in older patients: a systematic review and meta-analysis.PNG by Shuang Zhou (339964)

“…As various interventions have been developed to manage it, we performed a systematic review and meta-analysis to evaluate the effect of pharmaceutical interventions on outcomes of PIMs in older patients.…”

Table 1_A machine learning model to predict neurological deterioration after mild traumatic brain injury in older adults.docx by Daisu Abe (20498225)

“…Neurological deterioration was defined as a decrease of 2 or more points from a GCS score of 13 or more within 24 h of hospital admission. …”

How significant a role can China’s forest sector play in decarbonizing its economy? by Jianyun Hou (13018981)

Table_2_Character Strengths Predict an Increase in Mental Health and Subjective Well-Being Over a One-Month Period During the COVID-19 Pandemic Lockdown.docx by María Luisa Martínez-Martí (9544079)

“…A principal component analysis of character strengths was conducted. Five character strength factors were extracted: fortitude, goodness, intellectual, interpersonal, and restraint. …”

Presentation 1_Telehealth coaching in older adults, behavior change, and impacts of the COVID-19 pandemic: analyses from The Brain Health Champion Study.pdf by Brittany McFeeley (21104825)

“…Introduction<p>When COVID-19 containment strategies were imposed in March 2020, we became interested in how these restrictions might interfere with brain-healthy behaviors of older adults who were either actively participating in or who had recently completed our telehealth behavior change intervention. …”

DataSheet1_Inhibition of colon cancer K-RasG13D mutation reduces cancer cell proliferation but promotes stemness and inflammation via RAS/ERK pathway.PDF by Yan Qi (59532)

“…We found a close correlation of increased Lgr5 and CD133 with proinflammatory factors like IL-17, IL-22, and IL-23. …”

Pralidoxime in Acute Organophosphorus Insecticide Poisoning—A Randomised Controlled Trial by Michael Eddleston (53745)

“…</p><h3>Methods and Findings</h3><p>We performed a double-blind randomised placebo-controlled trial of pralidoxime chloride (2 g loading dose over 20 min, followed by a constant infusion of 0.5 g/h for up to 7 d) versus saline in patients with organophosphorus insecticide self-poisoning. …”

Supplementary Material for: Endothelial Dysfunction of the Peripheral Vascular Bed in the Acute Phase after Ischemic Stroke by Scherbakov N. (4129753)

“…A decreased RHI was observed in cardioembolic and lacunar infarcts and stroke of undetermined etiology (1.7 ± 0.4, 1.8 ± 0.5 and 1.7 ± 0.3, p < 0.0001). …”

Determinants of coronary flow reserve in non-diabetic patients with chest pain without myocardial perfusion defects by Helena U. Westergren (758365)

“…Secondly, we investigated association between cardiovascular parameters and decreased CFR in a sex specific manner.…”

The development of the glomerulocystic phenotype is progressively associated with loss of primary cilium. by Anna Iervolino (708944)

“…<p>Representative pictures of renal cortex from 50 days old Ctr (B) and Dicer cKO mice (A, C, D) stained for α-Acetylated Tubulin (green) and counterstained with Dapi (blue). …”

The PI3K/Akt- and NO-related pathways contribute to EPC tube formation affected by oxLDL. by Feng-Yen Lin (143413)

“…<p>(A and B) EPCs were treated for 2 hours with 0–50 μg/mL oxLDL, then eNOS and Akt activation (phosphorylation) was analyzed by Western blot. …”

Small molecule inhibitors of GSK-3β impede VEEV replication. by Kylene Kehn-Hall (45085)

“…<p><b>A</b>) U87MG astrocytes were treated with BIO (10, 5, 2.5, or 1.25 µM) and cell viability assayed 24 hours later by CellTiter Glo Assay (Promega). …”

Triptolide induces tRXRα degradation and AKT inactivation through activation of p38. by Na Lu (325317)

“…Triptolide-induced time-dependent phosphorylation of p38, JNK and Erk1/2 was compared to its effect on decreasing AKT phosphorylation and PARP cleavage. (B) HepG2 cells were treated with 50 nM triptolide for 9 h with or without p38 inhibitor SB203580 (10 µM), JNK inhibitor SP600125 (10 µM) or Erk1/2 MAPK inhibitor PD98059 (10 µM). …”

Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study by Anna Sidorchuk (313137)

“…Prescribing patterns were established in relation to duration (3 months, >3 to ≤6 months, or >6 months), dosage (<0.5 defined daily dosage [DDD]/day, ≥0.5 to <1.5 DDD/day, or ≥1.5 DDD/day), and “user category” (“regular users” [≥0.5 to <1.5 DDD/day for ≥1 year], “heavy users” [≥1.5 DDD/day for ≥1 year], or otherwise “occasional users”). …”